Tendyne Mitral Valve System
Device
Abbott Laboratories
Total Payments
$4.4M
Transactions
1,761
Doctors
176
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $2.9M | 1,228 | 142 |
| 2019 | $1.4M | 524 | 69 |
| 2018 | $134,484 | 9 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4.1M | 740 | 91.6% |
| Consulting Fee | $278,181 | 216 | 6.3% |
| Travel and Lodging | $64,021 | 275 | 1.4% |
| Food and Beverage | $22,031 | 526 | 0.5% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $6,400 | 3 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $500.00 | 1 | 0.0% |
Payments by Type
Research
$4.1M
740 transactions
General
$371,133
1,021 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation | Abbott Laboratories | $2.5M | 0 |
| Expanded Clinical Study of the Tendyne Mitral Valve System | Abbott Laboratories | $624,149 | 0 |
| Feasibility Study of the Tendyne Mitral Valve System for Use in Subjects With Mitral Annular Calcification | Abbott Laboratories | $278,349 | 1 |
| Early Feasibility Study of the Tendyne Mitral Valve System | Abbott Laboratories | $198,106 | 3 |
| A non-GLP acute study to evaluate Abbott's trans-septal mitral valve delivery catheter and Cephea mitral valve in swine and calf models | Abbott Laboratories | $163,490 | 0 |
| Feasibility study of the Tendyne Mitral Valve System in Mitral Annular Calcification | Abbott Laboratories | $150,381 | 0 |
| CEASE-MR | Abbott Laboratories | $90,949 | 7 |
Top Doctors Receiving Payments for Tendyne Mitral Valve System
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Cleveland, OH | $3.9M | 697 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Delray Beach, FL | $155,171 | 104 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Minneapolis, MN | $59,928 | 38 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Minneapolis, MN | $39,847 | 27 |
| , M.D | Cardiovascular Disease | Sacramento, CA | $39,775 | 19 |
| , M.D | Interventional Cardiology | Minneapolis, MN | $27,674 | 11 |
| , M.D | Cardiovascular Disease | Minneapolis, MN | $15,550 | 31 |
| , M.D | Internal Medicine | Boston, MA | $13,482 | 26 |
| , MD, PHD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Miami, FL | $13,475 | 27 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Washington, DC | $10,801 | 3 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Springfield, MO | $9,226 | 14 |
| , MD MSC | Cardiovascular Disease | Lees Summit, MO | $8,300 | 16 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Minneapolis, MN | $7,013 | 3 |
| , MD | Internal Medicine | Boston, MA | $5,150 | 9 |
| , M.D | Internal Medicine | Rochester, MN | $4,272 | 16 |
| , M.D., M.P.H | Internal Medicine | Boston, MA | $4,100 | 7 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Albany, NY | $3,756 | 12 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Minneapolis, MN | $3,300 | 1 |
| , MD | Clinical Cardiac Electrophysiology | New York, NY | $3,000 | 1 |
| , M.D | Neurology | Boston, MA | $2,325 | 6 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Boston, MA | $2,190 | 9 |
| , MD | Internal Medicine | Boston, MA | $2,000 | 3 |
| , MD | Advanced Heart Failure and Transplant Cardiology | Columbus, OH | $1,788 | 1 |
| , M.D | Cardiovascular Disease | Sacramento, CA | $1,782 | 2 |
| , M.D | Internal Medicine | Livingston, NJ | $1,586 | 9 |
Ad
Manufacturing Companies
- Abbott Laboratories $4.4M
Product Information
- Type Device
- Total Payments $4.4M
- Total Doctors 176
- Transactions 1,761
About Tendyne Mitral Valve System
Tendyne Mitral Valve System is a device associated with $4.4M in payments to 176 healthcare providers, recorded across 1,761 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2018 to 2020. In 2020, $2.9M was paid across 1,228 transactions to 142 doctors.
The most common payment nature for Tendyne Mitral Valve System is "Unspecified" ($4.1M, 91.6% of total).
Tendyne Mitral Valve System is associated with 7 research studies, including "Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation" ($2.5M).